Balyasny Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Hold
0
2288
2024
Q2
Hold
0
2318
2024
Q1
Sell
-50,503
Closed -$1.16M 2342
2023
Q4
$1.16M Buy
+50,503
New +$1.16M ﹤0.01% 1161
2018
Q3
Sell
-39,480
Closed -$265K 1700
2018
Q2
$265K Buy
39,480
+27,616
+233% +$185K ﹤0.01% 1375
2018
Q1
$102K Buy
+11,864
New +$102K ﹤0.01% 1639